Aromatase inhibitor

The purpose of a study was to evaluate the development in the use of medications associated with an increased risk...


Results of the global phase III SOLAR-1 trial evaluating the investigational alpha-specific PI3K inhibitor Alpelisib ( BYL719 ) has met...


Role of aromatase inhibitors and Zoledronic acid ( Zometa ) as adjuvant treatment of premenopausal endocrine-responsive breast cancer patients is...



Aromatase inhibitors effectively prevent breast cancer recurrence and development of new contralateral tumours in postmenopausal women. Researchers have assessed the...


The International Breast Cancer Study Group ( IBCSG ) has presented results of the randomized phase III SOFT trial at...


As predicted by their DNA-damaging mechanism of action, Platinum compounds are expected to be particularly active in tumours deficient of...


Patients with breast cancer are classified as having cells that over-express the human epidermal growth factor receptor 2 ( known...


The International Breast Cancer Study Group ( IBCSG ) has presented results of the randomized phase III SOFT clinical trial...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion recommending a variation to...


The American Society of Clinical Oncology ( ASCO ) issued a newly updated clinical practice guideline on pharmacological prevention interventions...


A new osteoporosis drug hinders the growth of estrogen-sensitive cancer that has become resistant to treatment with tamoxifen, a study...


A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for...


Amgen has informed physicians of important safety information for Prolia ( Denosumab ) and updates to the Prescribing Information.Prolia was...


Treatment with the aromatase inhibitor Letrozole ( Femara ) can reduce the risk of breast cancer recurrence even when initiated...


Treatment with the aromatase inhibitor Letrozole ( Femara ) can reduce the risk of breast cancer recurrence even when initiated...


As therapies for breast cancer continue to emerge, the issues of how to best monitor success and gauge prognosis remain...


Aromatase inhibitors carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of...


The largest study in the world of treatments for postmenopausal, hormone positive breast cancer has shown that patients who continue...


Osteoporosis is a growing concern among breast tumor survivors, because certain cancer drugs can cause bone loss.A new study has...